Edition No. 2
A new drug nearly doubled survival in advanced pancreatic cancer. Now the FDA has approved it.
September 6, 2026
Independent editorial publication
Editions · September 6, 2026
A clearer view of human progress.
Publication archive
Every weekly selection remains available here as the publication grows.
Edition No. 2
September 6, 2026
Edition No. 1
August 16, 2026